Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Language barriers, location of care, and delays in follow-up of abnormal mammograms.

Karliner LS, Ma L, Hofmann M, Kerlikowske K.

Med Care. 2012 Feb;50(2):171-8. doi: 10.1097/MLR.0b013e31822dcf2d.

2.

Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women.

Goldman LE, Walker R, Hubbard R, Kerlikowske K; Breast Cancer Surveillance Consortium.

Med Care. 2013 Apr;51(4):307-14. doi: 10.1097/MLR.0b013e318280f04c.

3.

Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.

Hubbard RA, Zhu W, Horblyuk R, Karliner L, Sprague BL, Henderson L, Lee D, Onega T, Buist DS, Sweet A.

Breast Cancer Res Treat. 2013 Apr;138(3):879-87. doi: 10.1007/s10549-013-2466-5. Epub 2013 Mar 8.

4.

Accuracy of diagnostic mammography at facilities serving vulnerable women.

Goldman LE, Walker R, Miglioretti DL, Smith-Bindman R, Kerlikowske K; National Cancer Institute Breast Cancer Surveillance Consortium.

Med Care. 2011 Jan;49(1):67-75. doi: 10.1097/MLR.0b013e3181f380e0.

5.

Factors influencing time to diagnosis after abnormal mammography in diverse women.

Pérez-Stable EJ, Afable-Munsuz A, Kaplan CP, Pace L, Samayoa C, Somkin C, Nickleach D, Lee M, Márquez-Magaña L, Juarbe T, Pasick RJ.

J Womens Health (Larchmt). 2013 Feb;22(2):159-66. doi: 10.1089/jwh.2012.3646. Epub 2013 Jan 25.

6.
7.

Facility characteristics do not explain higher false-positive rates in diagnostic mammography at facilities serving vulnerable women.

Goldman LE, Walker R, Miglioretti DL, Smith-Bindman R, Kerlikowske AK; Breast Cancer Surveillance Consortium.

Med Care. 2012 Mar;50(3):210-6. doi: 10.1097/MLR.0b013e3182407c8a.

8.
9.

What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.

Yabroff KR, Breen N, Vernon SW, Meissner HI, Freedman AN, Ballard-Barbash R.

Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):723-32.

10.

Communication factors in the follow-up of abnormal mammograms.

Poon EG, Haas JS, Louise Puopolo A, Gandhi TK, Burdick E, Bates DW, Brennan TA.

J Gen Intern Med. 2004 Apr;19(4):316-23.

11.

Timing of follow-up after abnormal screening and diagnostic mammograms.

Wernli KJ, Aiello Bowles EJ, Haneuse S, Elmore JG, Buist DS.

Am J Manag Care. 2011 Feb;17(2):162-7.

12.

Frequency and predictive value of a mammographic recommendation for short-interval follow-up.

Yasmeen S, Romano PS, Pettinger M, Chlebowski RT, Robbins JA, Lane DS, Hendrix SL.

J Natl Cancer Inst. 2003 Mar 19;95(6):429-36.

13.

Access to diagnostic mammography in the San Francisco Bay Area.

Dinkelspiel E, Chu P, Smith-Bindman R.

J Womens Health (Larchmt). 2008 Jun;17(5):893-9. doi: 10.1089/jwh.2007.0638.

PMID:
18537490
14.

Mammography capacity and appointment wait times: barriers to breast cancer screening.

Elkin EB, Snow JG, Leoce NM, Atoria CL, Schrag D.

Cancer Causes Control. 2012 Jan;23(1):45-50. doi: 10.1007/s10552-011-9853-1. Epub 2011 Oct 29.

15.

Variability of interpretive accuracy among diagnostic mammography facilities.

Jackson SL, Taplin SH, Sickles EA, Abraham L, Barlow WE, Carney PA, Geller B, Berns EA, Cutter GR, Elmore JG.

J Natl Cancer Inst. 2009 Jun 3;101(11):814-27. doi: 10.1093/jnci/djp105. Epub 2009 May 26.

16.

Compliance and self-reported barriers to follow-up of abnormal screening mammograms among women utilizing a county mobile mammography van.

Peek ME, Han JH.

Health Care Women Int. 2009 Oct;30(10):857-70. doi: 10.1080/07399330903066350.

PMID:
19742361
17.

Breast cancer stage at diagnosis: is travel time important?

Henry KA, Boscoe FP, Johnson CJ, Goldberg DW, Sherman R, Cockburn M.

J Community Health. 2011 Dec;36(6):933-42. doi: 10.1007/s10900-011-9392-4.

PMID:
21461957
18.

Realizing the promise of breast cancer screening: clinical follow-up after abnormal screening among Black women.

Kerner JF, Yedidia M, Padgett D, Muth B, Washington KS, Tefft M, Yabroff KR, Makariou E, Freeman H, Mandelblatt JS.

Prev Med. 2003 Aug;37(2):92-101.

PMID:
12855208
19.

Social service barriers delay care among women with abnormal cancer screening.

Primeau SW, Freund KM, Ramachandran A, Bak SM, Heeren T, Chen CA, Morton S, Battaglia TA.

J Gen Intern Med. 2014 Jan;29(1):169-75. doi: 10.1007/s11606-013-2615-x. Epub 2013 Oct 3.

20.

Follow-up among women with an abnormal mammogram in an HMO: is it complete, timely, and efficient?

Burack RC, Simon MS, Stano M, George J, Coombs J.

Am J Manag Care. 2000 Oct;6(10):1102-13.

Items per page

Supplemental Content

Write to the Help Desk